References
- Fukama M., Fujita H., Seto Y., Fukushima K., Sugimoto Y., Sakurai T., Tomioka H., Hoshino T., Yagi T., Sowa T., Toyoshima S. Distribution and excretion of tritiated N4-behenoyl-1-β-D-arabinofuranosylcytosine (BH-AC) in mice. Cancer and Chemotherapy 1980; 7: 2109–2118
- Kawai M., Esumi Y., Ishizaki M., Gunji S., Seki H. Metabolism of gemcitabine in rats and dogs. Xenobiotica 1994, submitted
- Heinemann V., Hertel L. W., Grindey G. B., Plunkett W. Comparison of the cellular pharmacokinetics and toxicity of 2′,2′-difluoro-deoxycytidine and 1-β-D-arabinofuranosyl-cytosine. Cancer Research 1988; 48: 4024–4031
- Hertel L. W., Boder G. B., Kroin J. S., Rinzel S. M., Poore G. A., Todd G. C., Grindey G. B. Evaluation of the antitumor activity of gemcitabine (2′,2′-difluro-2′-deoxycytidine). Cancer Research 1990; 50: 4417–4422
- Hertel L. W., Kroin J. S., Misner J. W., Tustin J. M. Synthesis of 2-deoxy-2,2-difluoro-D-ribose and 2-deoxy-2,2-difluoro-D-ribofuranosyl nucleosides. Journal of Organic Chemistry 1988; 53: 2406–2409
- Plunkett W., Gandhi V., Chubb S., Nowak B., Heinemann V., Mineishi S., Sen A., Hertel L. W., Grindey G. B. 2′,2′-Difluorodeoxycytidine metabolism and mechanism of action in human leukemia cells. Nucleosides and Nucleotides 1989; 8: 775–785
- Shipley L. A., Brown T. J., Cornpropst J. D., Hamilton M., Daniels W. D., Culp H. W. Metabolism and disposition of gemcitabine, an oncolytic deoxycytidine analog, in mice, rats, and dogs. Drug Metabolism and Disposition 1992; 20: 849–855